Skip to content

Simulations Plus SLP Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
NeoGenomics logo
NeoGenomicsNEO
Revvity logo
RevvityRVTY
Agilent Technologies logo
Agilent TechnologiesA
Azenta logo
AzentaAZTA
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP

Other financials

Income statement

See full
Revenue$24.3M+8.3%
Gross profit$16.1M+23.0%
Operating income$5.6M+108%
Net income$4.5M+47.5%
EPS (diluted)$0.22+46.7%

Balance sheet

See full
Cash & equivalents$25.7M+134%
Total debt$508.0K-36.2%
Total equity$133.8M-29.4%
Total assets$146.5M-27.3%

Cash flow

See full
Operating cash flow$6.4M+13.1%
CapEx$46.0K-30.3%
Free cash flow$6.4M+13.6%

Valuation

See full
Market cap$366.73M+5.2%
Enterprise value$341.51M+6.0%
P/S4.6×+0.2×

Profitability

See full
Gross margin62%+6.7pp
Operating margin-84.3%
Net margin-78%-87.2pp
FCF margin29.5%+14.9pp

Returns & leverage

See full
Return on equity-38.8%-42.8pp
Debt / equity0.0×
Current ratio5.5×+1.1×

Where this comes from

Reported directly by Simulations Plus in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Simulations Plus’s 10-Q, filed April 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Simulations Plus's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Simulations Plus's common stock, shares issued (in shares)?
Simulations Plus (SLP) reported common stock, shares issued (in shares) of $20.21M in Q4 2025.
How has Simulations Plus's common stock, shares issued (in shares) changed year-over-year?
Simulations Plus's common stock, shares issued (in shares) increased by 0.5% year-over-year, from $20.11M to $20.21M.
What is the long-term trend for Simulations Plus's common stock, shares issued (in shares)?
Over 5 years (2020 to 2025), Simulations Plus's common stock, shares issued (in shares) has grown at a 0.2% compound annual growth rate (CAGR), from $19.92M to $20.14M.